文献速递头颈部肿瘤放疗

放疗时段与季节对头颈癌预后的影响

The prognostic impact of daytime and seasonality of radiotherapy on head and neck cancer.
PubMed 文献 · Radiother Oncol · 2021-04-20

按治疗季节分为DARK与LIGHT两组,DARK组5年局部区域控制率和无进展生存率均优于LIGHT组,而每日放疗时段未影响预后。

要点

  • DARK季放疗5年局部区域控制73%对61%,无进展生存51%对43%。
  • 每日放疗时段(上午或下午)对预后无显著影响。
  • 季节与预后的生物学机制不明,结果需外部验证。

核心结论

  • 治疗季节为DARK时局部区域控制和无进展生存优于LIGHT,每日放疗时段不影响预后。

主要发现

  • DARK组5年局部区域控制率73%,LIGHT组61%,P=0.0108。
  • DARK组5年无进展生存率51%,LIGHT组43%,P=0.0374。
  • DARK与LIGHT两组间患者、肿瘤和治疗特征无显著异质性,每日分次放疗时段中位数亦无差异(X2 P>0.05)。
  • 每日放疗时段及其他治疗时间相关参数均未影响预后。

临床怎么用

  • 暂不能依据治疗季节或每日时段调整头颈鳞癌放疗安排,需外部验证后再考虑。

局限性

  • 为回顾性队列研究,季节影响预后的生物学机制尚不明确,结果需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The potential impact of daytime and season of radiotherapy application on prognosis is unclear. This was analyzed in a retrospective cohort of patients who were diagnosed with non-metastatic head and neck squamous cell carcinoma (HNSCC) and treated with definitive radiotherapy with or without chemotherapy. MATERIALS AND METHODS: Patient and tumor characteristics, treatment parameters and outcome until last follow-up or death were obtained. Median radiotherapy delivery daytime of each patient was categorized as morning (AM) and afternoon (PM). Treatment season was defined by median date of treatment course. Each year was divided into DARK and LIGHT according to equinoxes. Time-to-event endpoints were defined by first biopsy confirming the HNSCC. RESULTS: Six hundred fifty-five cases were identified who were treated with (chemo)radiotherapy between 2002 and 2015. Median follow-up was 47 months. No significant heterogeneity in patient, tumor and treatment characteristics were observed between DARK and LIGHT or regarding median daily fraction time (X2 p > 0.05). Five-year loco-regional control (73% vs. 61%; p = 0.0108) and progression-free survival (51% vs. 43%; p = 0.0374) were superior when radiotherapy was administered in DARK. Neither the daytime nor any other treatment time-related parameter affected prognosis. CONCLUSION: This is the first study investigating and presenting the prognostic impact of seasonality regarding the treatment course on loco-regional control and progression-free survival (DARK > LIGHT). The biological mechanism of action is unclear. These results should be interpreted with caution and our findings have to be validated externally.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Elicin O, Koller Brolese E, Bojaxhiu B, et al. The prognostic impact of daytime and seasonality of radiotherapy on head and neck cancer. Radiother Oncol. 2021. PMID: 33848563. doi:10.1016/j.radonc.2021.04.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。